Treatment with Optifast reduces hepatic steatosis and increases candidacy rates for living donor liver transplantation.
| Image |  |
|---|---|
| Description | scientific article published in September 2016 |
| Author/s | |
| Publication date | September 1, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |